The mapping of the human genome was seen as a true breakthrough in science. It solidified more of our understanding of the human body and its chemistry. Some did question the need for mapping the human genome. Proponents of the task spoke of the ability to identify individuals that are predisposed to developing or passing on certain genetic ailments. Companies are seeking to patent certain gene sequences. Allowing this would give that company or entity total control of those particular gene sequences. They would basically own the gene sequences. When considering precedence setting decisions, governing groups should carefully weigh the unforeseen tragedies that could arise. Abuse is clearly a concern when human gene sequences can owned by an entity. The past has shown us that entities that have such control over genetic information will use this power for either financial gain or to limit access to the genetic information. One such company is Monsanto. They own the patents on several seed lines as well as a patent on a herbicide. They have used the court system to enforce their patent privilege. They have won all of the lawsuits that they have brought forth. Suits against farmers for the use of their patented seeds. Imagine what would happen if another company can patent a gene sequence that belongs to a human being. How much control could they hold over your grandmother, your children. How much control could they have over your physician. In some cases, the patent may prevent your doctor from even testing you for the gene sequence. The need to understand our biology and chemistry is vitally important and should be encouraged, but the desire to profit from such information should be discouraged and possibly outlawed.